Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2020

Nov 18, 2020

29755_dirs_2020-11-18_7d25a121-88b0-47eb-8174-e033009dba25.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-11-16

Reporting Person: ALBAN CARLOS (Vice Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-16 Common Stock, $0.01 par value M 115830 $35.88 Acquired 230729 Direct
2020-11-16 Common Stock, $0.01 par value S 115830 $100.00 Disposed 114899 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-16 Option(Right to buy) $35.88 M 115830 Disposed 2023-02-13 Common Stock (115830) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, $0.01 par value 40442 Indirect

Footnotes

F1: Held in the Maria Cristina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust.

F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.